These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12704102)

  • 1. Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis.
    de Jonge MI; Vidarsson G; van Dijken HH; Hoogerhout P; van Alphen L; Dankert J; van der Ley P
    Infect Immun; 2003 May; 71(5):2331-40. PubMed ID: 12704102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.
    de Jonge MI; Hamstra HJ; Jiskoot W; Roholl P; Williams NA; Dankert J; van Alphen L; van der Ley P
    Vaccine; 2004 Sep; 22(29-30):4021-8. PubMed ID: 15364452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.
    Zariri A; van Dijken H; Hamstra HJ; van der Flier M; Vidarsson G; van Putten JP; Boog CJ; van den Dobbelsteen G; van der Ley P
    Vaccine; 2013 Nov; 31(47):5585-93. PubMed ID: 23933369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.
    de Jonge MI; Hamstra HJ; van Alphen L; Dankert J; van der Ley P
    Mol Microbiol; 2003 Nov; 50(3):1005-15. PubMed ID: 14617157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.
    Wright JC; Williams JN; Christodoulides M; Heckels JE
    Infect Immun; 2002 Aug; 70(8):4028-34. PubMed ID: 12117908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.
    Steeghs L; Kuipers B; Hamstra HJ; Kersten G; van Alphen L; van der Ley P
    Infect Immun; 1999 Oct; 67(10):4988-93. PubMed ID: 10496868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
    Callaghan MJ; Lewis S; Sadarangani M; Bailey SE; Chan H; Ferguson DJ; Derrick JP; Feavers I; Maiden MC; Pollard AJ
    Infect Immun; 2011 Jul; 79(7):2810-8. PubMed ID: 21464082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.
    Pettersson A; Kortekaas J; Weynants VE; Voet P; Poolman JT; Bos MP; Tommassen J
    Vaccine; 2006 Apr; 24(17):3545-57. PubMed ID: 16517031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of opacity proteins from Neisseria meningitidis.
    de Jonge MI; Bos MP; Hamstra HJ; Jiskoot W; van Ulsen P; Tommassen J; van Alphen L; van der Ley P
    Eur J Biochem; 2002 Nov; 269(21):5215-23. PubMed ID: 12392553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.
    Hung MC; Humbert MV; Laver JR; Phillips R; Heckels JE; Christodoulides M
    Vaccine; 2015 Aug; 33(36):4486-94. PubMed ID: 26207592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
    Christodoulides M; Brooks JL; Rattue E; Heckels JE
    Microbiology (Reading); 1998 Nov; 144 ( Pt 11)():3027-3037. PubMed ID: 9846738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis.
    Hoogerhout P; Donders EM; van Gaans-van den Brink JA; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; ten Hove GJ; de Jong AP; Peeters CC
    Infect Immun; 1995 Sep; 63(9):3473-8. PubMed ID: 7543883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.
    Humphries HE; Williams JN; Blackstone R; Jolley KA; Yuen HM; Christodoulides M; Heckels JE
    Vaccine; 2006 Jan; 24(1):36-44. PubMed ID: 16105711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
    Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
    Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
    Sadarangani M; Hoe JC; Callaghan MJ; Jones C; Chan H; Makepeace K; Daniels-Treffandier H; Deadman ME; Bayliss C; Feavers I; van der Ley P; Pollard AJ
    PLoS One; 2012; 7(12):e51045. PubMed ID: 23251421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.
    Jansen C; Kuipers B; van der Biezen J; de Cock H; van der Ley P; Tommassen J
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):227-33. PubMed ID: 10683467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.